Postmortem toxicology of carbamazepine

Journal of Analytical Toxicology

Volumn 27, Issue 4, 2003, Pages 243-248

  Klys, Malgorzata ^a   Bystrowska, Beata ^a   Bujak Gizycka, Beata ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

10,11 DIHYDRO 10,11 DIHYDROXYCARBAMAZEPINE; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; DRUG METABOLITE;

ARTICLE; AUTOPSY; BODY FLUID; CONCENTRATION RESPONSE; DRUG INTOXICATION; FATALITY; HUMAN; HUMAN TISSUE; METABOLIC RATE; TOXICOLOGY;

EID: 0037605910     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/27.4.243     Document Type: Article

References (25)

1. R.C. Baselt and R.H. Cravey. Disposition of Toxic Drugs and Chemicals in Man, 4th ed. Chemical Toxicology Institute, Foster City, CA, 1995.
2. R.H. Levy, A.J. Wilensky, and G.D. Anderson. Carbamazepine, valproic acid, phenobarbital, and ethisuximide. In Applied Pharmacokinetics Principles of Therapeutic Drug Monitoring, W.E. Evans, J.J. Schentag, and W.J. Jusko, Eds. Lippincott, Williams & Wilkins, Philadelphia, PA, 1992.
3. W. Daniel, L. Janczar, L. Danek, W. Legrum, and K.J. Netter. Pharmacokinetic interaction between carbamazepine and neuroleptics after combined prolonged treatment in rats. Naunyn-Schmiedeberg's Arch Pharmacol. 145: 598-605 (1992).
4. R. Causon. Validation of chromatographic methods in biomedical analysis. Viewpoint and discussion. J. Chromatogr. B 689: 175-180 (1997).
5. F. Bressolle, M. Bromet-Petit, and M. Audran. Validation of liquid chromatographic and gas chromatographic methods. Application to pharmacokinetics. J. Chromatogr. B 686: 3-10 (1996).
6. M. Dalpe-Scott, M. Degouffe, D. Garbutt, and M. Drost. A comparison of drug concentrations in in postmortem cardiac and peripheral blood in 320 cases. Can. Soc. Forensic Sci. J. 28: 113-121 (1995).
7. Body fluids postmortem material. In Clark's Isolation and Identification of Drugs and Pharmaceuticals, A.C. Moffat and E.C.G. Clarke, Eds. The Pharmaceutical Press, London, England, 1986, pp 428-429.
8. W. Daniel. Metabolism of psychotropic drugs: pharmacological and clinical relevance. Pol. J. Pharmacol. 47: 367-379 (1995).
9. J.L. Maggs, N.R. Pirmohamed, N.R. Kitteringam, and B.K. Park. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry. Drug Metab. Dispos. 25: 275-280 (1997).
10. A.H. Stead and A.C. Moffat. A collection of therapeutic, toxic and fatal blood drug concentrations in man. Hum. Toxicol. 3: 437-464 (1983).
11. H. Druid and P. Holmgren. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J. Forensic Sci. 4: 79-87 (1997).
12. D.R.A. Uges. Therapeutic and toxic drug concentrations. The Bulletin of the International Association of Forensic Toxicologists, Supplement 26/1. Quo's Printing, Fountain Valley, CA, p 8.
13. D.F. Weaver. Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes. Neurology 38: 755-759 (1998).
14. A.G. Fraser. Pharmacokinetic interactions between alcohol and other drugs. Clin. Pharmacokinet. 33: 79-90 (1997).
15. H. Thabet, N. Brahmi, J. Zagdoudi, M. Amamou, A. Hedhili, N. Ben Salah, and M. Yacoub. Acute self-induced poisoning with carbamazepine (in French). Presse Med. 28: 955-958 (1999).
16. T. Rosel, J. Schneider, J.T. Fischer, and K.F. Druschky. Carbamazepine poisonings caused by confusing the drugs (in German). Dtsch. Med. Wochenschr. 125: 352-356 (2000).
17. T. Tateishi, M. Asoh, H. Nakura, M. Watanabe, M. Tanaka, T. Kumai, and S. Kobayashi. Carbamazepine induces multiple cytochrome P450 subfamilies in rats. Chem. Biol. Interact. 117: 257-268 (1999).
18. W.W. Shen. Cytochrome P450 monooxygenases and interactions of psychotropic drugs: a five-year update. Int. J. Psychiatry Med. 25: 286-290 (1995).
19. W.W. Shen. The metabolism of psychoactive drugs: a review of enzymatic biotransformation and inhibition. Soc. Biol. Psychiatry 41: 814-826 (1997).
20. M. Bertram, C.W. Fabien, S. Schwarz, and S. Achwab. Massive carbamazepine overdose: clinical and neurophysiological findings. J. Neurol. 245: 745-747 (1998).
21. J.J. Sue and M. Shannon. Pharmacokinetics of drugs in overdose. Clin. Pharmacokinet. 23: 93-105 (1992).
22. J. Rosenberg, N.L. Benowitz, and S. Pond. Pharmacokinetics of drug overdose. Clin Pharmacokinet. 6: 161-192 (1981).
23. T. May, U. Jurgens, B. Ranbeck, and R. Schnabel. Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsy. Epilepsy Res. 33: 57-65 (1999).
24. F.S. Apple. Postmortem tricyclic concentrations: assesing cause of death using parent drug to metabolite ratio. J. Anal. Toxicol. 13: 197-198 (1989).
25. H. Druid, P. Holmgren, B. Carlsson, and J. Ahlner. Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results. Forensic Sci. Int. 99: 25-34 (1999).